Dermapharm Holding SE (ETR:DMP)
48.75
-0.35 (-0.71%)
May 29, 2026, 5:35 PM CET
Dermapharm Holding SE Employees
Dermapharm Holding SE had 3,503 employees as of December 31, 2025. The number of employees decreased by 107 or -2.96% compared to the previous year.
Employees
3,503
Change
-107
Growth
-2.96%
Revenue / Employee
€337,491
Profits / Employee
€41,167
Market Cap
2.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3,503 | -107 | -2.96% |
| Jun 30, 2025 | 3,551 | -52 | -1.44% |
| Dec 31, 2024 | 3,610 | 113 | 3.23% |
| Jun 30, 2024 | 3,603 | 199 | 5.85% |
| Dec 31, 2023 | 3,497 | 934 | 36.44% |
| Jun 30, 2023 | 3,404 | 831 | 32.30% |
| Dec 31, 2022 | 2,563 | 190 | 8.01% |
| Jun 30, 2022 | 2,573 | 210 | 8.89% |
| Dec 31, 2021 | 2,373 | 62 | 2.68% |
| Jun 30, 2021 | 2,363 | 200 | 9.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,783 |
| Bayer Aktiengesellschaft | 87,757 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| Fielmann Group AG | 18,928 |
| Drägerwerk AG & Co. KGaA | 16,033 |
| Gerresheimer AG | 13,535 |
| Ottobock SE & Co. KGaA | 10,365 |
Dermapharm Holding SE News
- 14 days ago - EQS-DD: Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy - Wallstreet:Online
- 16 days ago - Dermapharm Holding SE Earnings Call Transcript: Q1 2026 - Transcripts
- 16 days ago - Dermapharm Holding SE Slides: Q1 2026 - Filings
- 16 days ago - Dermapharm Holding SE Quarterly report: Q1 2026 - Filings
- 25 days ago - EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 5 weeks ago - EQS-NVR: Dermapharm Holding SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 7 weeks ago - EQS-PVR: Dermapharm Holding SE: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG - Wallstreet:Online
- 2 months ago - Dermapharm Holding SE Earnings Call Transcript: Q4 2025 - Transcripts